These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 12913240

  • 1. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
    Saravanan M, Sri Nataraj K, Ganesh KS.
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y, Khanvilkar KH, Moore AD, Hilliard-Lott M.
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D, Ojsteršek T, Vrečer F.
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
    [Abstract] [Full Text] [Related]

  • 6. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.
    Park C, Lee JH, Jin G, Ngo HV, Park JB, Tran TTD, Tran PHL, Lee BJ.
    Curr Drug Deliv; 2022 Sep; 19(5):520-533. PubMed ID: 34420504
    [Abstract] [Full Text] [Related]

  • 7. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
    Kadivar A, Kamalidehghan B, Javar HA, Davoudi ET, Zaharuddin ND, Sabeti B, Chung LY, Noordin MI.
    PLoS One; 2015 Sep; 10(6):e0126874. PubMed ID: 26035710
    [Abstract] [Full Text] [Related]

  • 8. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
    Wu B, Shun N, Wei X, Wu W.
    Pharm Dev Technol; 2007 Sep; 12(2):203-10. PubMed ID: 17510892
    [Abstract] [Full Text] [Related]

  • 9. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.
    Reddy KR, Mutalik S, Reddy S.
    AAPS PharmSciTech; 2003 Dec 12; 4(4):E61. PubMed ID: 15198556
    [Abstract] [Full Text] [Related]

  • 10. Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam.
    Mahaguna V, Talbert RL, Peters JI, Adams S, Reynolds TD, Lam FY, Williams RO.
    Eur J Pharm Biopharm; 2003 Nov 12; 56(3):461-8. PubMed ID: 14602191
    [Abstract] [Full Text] [Related]

  • 11. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS, Saha RN.
    Drug Deliv; 2008 Nov 12; 15(3):159-68. PubMed ID: 18379928
    [Abstract] [Full Text] [Related]

  • 12. Captopril floating and/or bioadhesive tablets: design and release kinetics.
    Nur AO, Zhang JS.
    Drug Dev Ind Pharm; 2000 Sep 12; 26(9):965-9. PubMed ID: 10914320
    [Abstract] [Full Text] [Related]

  • 13. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
    Chen L, Wang F.
    Pharmazie; 2013 Oct 12; 68(10):796-9. PubMed ID: 24273882
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH, Tazeen J, Merchant HA, Yousuf RI.
    Pak J Pharm Sci; 2006 Apr 12; 19(2):119-24. PubMed ID: 16751122
    [Abstract] [Full Text] [Related]

  • 15. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME.
    Drug Dev Ind Pharm; 2013 Nov 12; 39(11):1651-62. PubMed ID: 23094867
    [Abstract] [Full Text] [Related]

  • 16. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D, Vrečer F.
    Drug Dev Ind Pharm; 2017 Feb 12; 43(2):329-337. PubMed ID: 27739880
    [Abstract] [Full Text] [Related]

  • 17. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.
    Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodríguez F, Heinämäki J.
    Int J Pharm; 2006 Jul 06; 317(1):32-9. PubMed ID: 16584856
    [Abstract] [Full Text] [Related]

  • 18. Study of the influence of cellulose derivatives on physical and analytical attributes of a drug product belonging to BCS class II.
    Domosławska M, Pawlak-Morka R, Dobrzyński Ł, Herda M.
    Polim Med; 2018 Jul 06; 48(2):83-90. PubMed ID: 31111692
    [Abstract] [Full Text] [Related]

  • 19. Core-in-cup tablet design of metoprolol succinate and its evaluation for controlled release.
    Nagaraju R, Meera DS, Kaza R, Arvind VV, Venkateswarlu V.
    Curr Drug Discov Technol; 2009 Dec 06; 6(4):299-305. PubMed ID: 20025598
    [Abstract] [Full Text] [Related]

  • 20. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB, Lim J, Kang CY, Lee BJ.
    Curr Drug Deliv; 2013 Dec 06; 10(6):732-41. PubMed ID: 23855499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.